Antimicrobial stewardship practices in the intensive care unit: a pre–post interventional study
Open Access
- 24 September 2026
- journal article
- Published by Turkish Society of Intensive Care in Turkish Journal of Intensive Care
- Vol. 24 (3) , 165-172
Abstract
Objective: This study aims to assess the frequency of drug-related problems (DRPs) related to antimicrobial drugs in the ICU and to examine changes in the use of antibiotics in the ‘Reserve’ group of the World Health Organization (WHO) AWaRe classification during the antimicrobial stewardship (AMS) team intervention, including the clinical pharmacist. Methods: In this single-center intervention study, the pre-intervention period between November 2021 and August 2022 and the post-intervention period between November 2022 and August 2023 were evaluated. In the post-intervention period, a clinical pharmacist was also included in the AMS team. Post-intervention medication-related problems (DRPs) were categorized using only the “problem” and “cause” domains of the Pharmaceutical Care Network Europe (PCNE) V9.1 classification system. Additionally, recommendations and their acceptance rates were recorded. The antibiotic use density of the ‘Reserve’ group, defined in the WHO AWaRe classification, was evaluated in terms of days of therapy (DOT) per 1000 patient-days. Results: After the intervention, 175 DRPs were detected in 67.1% of 173 patients; 70% were related to antimicrobial drugs. The 90.1% of the interventions suggested by the clinical pharmacist were evaluated and accepted by infectious diseases and intensive care specialists. The total use of “Reserve” group antibiotics decreased, but not significantly; significant decreases were observed for some agents such as linezolid and daptomycin. Conclusion: Multidisciplinary antimicrobial stewardship practices involving the clinical pharmacist can contribute to the prevention of antimicrobial resistance development by facilitating the detection and solution of DRPs, especially by reducing the use of ‘Reserve’ group antimicrobials.Keywords
This publication has 21 references indexed in Scilit:
- Battle of polymyxin induced nephrotoxicity: Polymyxin B versus colistinInternational Journal of Antimicrobial Agents, 2023
- Challenges of implementing antimicrobial stewardship tools in Low to Middle Income Countries (LMICs)Infection Prevention in Practice, 2023
- Impact of clinical pharmacist’s interventions on clinical outcomes in appropriate use of colistin: a prospective pre-post intervention studyJournal of Chemotherapy, 2023
- Benefits of pharmacist intervention in the critical care patients with infectious diseases: A propensity score matching retrospective cohort studyAustralian Critical Care, 2023
- Impact of ward pharmacist-led antimicrobial stewardship in intensive care unitsJournal of Chemotherapy, 2022
- Sustaining Antimicrobial Stewardship in a High–Antibiotic Resistance SettingJAMA Network Open, 2022
- Global burden of bacterial antimicrobial resistance in 2019: a systematic analysisThe Lancet, 2022
- Polymyxin-induced nephrotoxicity and its predictors: a systematic review and meta-analysis of studies conducted using RIFLE criteria of acute kidney injuryPharmacological Research, 2021
- Antibiotic overconsumption and resistance in TurkeyClinical Microbiology and Infection, 2019
- Pharmacist-driven antimicrobial stewardship in intensive care units in East China: A multicenter prospective cohort studyAmerican Journal of Infection Control, 2017